POSC262 Exploring Health Technology Assessment (HTA) Acceptance of Disease-Free Survival (DFS) as an Appropriate Endpoint in Early-Stage, Non-Metastatic Solid Tumours
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.900
https://www.valueinhealthjournal.com/article/S1098-3015(21)02695-4/fulltext
Title :
POSC262 Exploring Health Technology Assessment (HTA) Acceptance of Disease-Free Survival (DFS) as an Appropriate Endpoint in Early-Stage, Non-Metastatic Solid Tumours
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02695-4&doi=10.1016/j.jval.2021.11.900
First page :
Section Title :
Open access? :
No
Section Order :
10431